 |
Exisulind |
|---|---|
| Trade Name | |
| Orphan Indication | For the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli |
| USA Market Approval | USA |
| USA Designation Date | 1994-02-14 00:00:00 |
| Sponsor | OSI Pharmaceuticals, Inc.;41 Pinelawn Road;Melville, New York, 11747 |
